Latest News and Press Releases
GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.
www.globenewswire.comHere are the latest publicly reported developments on Semaglutide sold online and related safety concerns.
-
WHO alert on falsified semaglutide: The World Health Organization issued a medical product alert in 2024 regarding three batches of falsified semaglutide (brand Ozempic) distributed in certain countries, highlighting risks from counterfeit products and potential safety issues. This signals ongoing global vigilance about online and informal supply channels.[6]
-
US regulatory warnings about online sellers: In 2023, the U.S. FDA issued warning letters to online vendors (e.g., Semaspace, Gorilla Healing) for selling unapproved semaglutide and tirzepatide, underscoring that only Wegovy (semaglutide) approved for obesity and Ozempic/Rybelsus for diabetes have regulatory approval, with enforcement actions possible if unapproved products continue.[2]
-
Research on online purchases without prescription: A JAMA Network Open study (2024) analyzed online semaglutide purchases and found a substantial portion of online activity linked to illegal pharmacies, with some products lacking active ingredients or being misrepresented; the study also notes FDA warning letters and ongoing concerns about product quality and safety when sourcing online.[3]
-
Consumer risk and supply dynamics: Coverage in 2024–2025 notes continued high demand for Wegovy and supply constraints, with manufacturers increasing production efforts. This context raises consumer interest in legitimate access versus online remedies, especially given the broader regulatory and safety warnings around online sources.[1]
If you want, I can summarize key safety tips for discussing semaglutide with a clinician, or help locate reputable sources for patient information about Wegovy and Ozempic, including official FDA or manufacturer guidance. Would you like a concise FAQ-style guide or a side-by-side comparison of approved products and common online-sourcing risks?
Citations:
- WHO alert on falsified semaglutide.[6]
- FDA warning letters to online vendors.[2]
- JAMA Network Open study on no-prescription online semaglutide purchases.[3]
- Novo Nordisk supply update and context on Wegovy demand.[1]